Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure

Cardiovascular Diabetology

Volumn 7, Issue , 2008, Pages

  Miyashita, Yumi ^a   Nishimura, Rimei ^a   Nemoto, Masami ^a   Matsudaira, Toru ^a   Kurata, Hideaki ^a   Yokota, Tamotsu ^a   Yokota, Kuninobu ^a   Tojo, Katsuyoshi ^a   Utsunomiya, Kazunori ^a   Tajima, Naoko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ALPHA GLUCOSIDASE INHIBITOR; BIPHASIC INSULIN; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN SENSITIZING AGENT; ISOPHANE INSULIN; METFORMIN; NOVORAPID 30 MIX; ORAL ANTIDIABETIC AGENT; PHENYLALANINE DERIVATIVE; SULFONYLUREA; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC PATIENT; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTIMA; MALE; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TUNICA MEDIA; VASCULAR DISEASE; BLOOD; DISEASE COURSE; DOSE RESPONSE; DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATHOLOGY; QUALITY OF LIFE; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADIPONECTIN; ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SINGLE-BLIND METHOD; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME; TUNICA INTIMA; TUNICA MEDIA;

EID: 47349095951     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-7-16     Document Type: Article

References (27)

1. Standards of medical care in diabetes-2007 Diabetes Care 2007, 30(Suppl 1):S4-S41. 17192377
2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med 1993, 329(14):977-986. 10.1056/NEJM199309303291401 8366922
3. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT) Diabetologia 1998, 41(4):416-423. 10.1007/s001250050924 9562345
4. Ohkubo Y Kishikawa H Araki E Miyata T Isami S Motoyoshi S Kojima Y Furuyoshi N Shichiri M Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study Diabetes Res Clin Pract 1995, 28(2):103-117. 10.1016/ 0168-8227(95)01064-K 7587918
5. JDFI Current status, Future Directions Report of the Juvenile Diabetes Foundation International World Conference on Diabetes Research: 1985; monaco 1985.
6. Balkau B Hu G Qiao Q Tuomilehto J Borch-Johnsen K Pyorala K Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor. The DECODE Study Diabetologia 2004, 47(12):2118-2128. 10.1007/s00125-004-1574-5 15662552
7. Tominaga M Eguchi H Manaka H Igarashi K Kato T Sekikawa A Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study Diabetes Care 1999, 22(6):920-924. 10.2337/diacare.22.6.920 10372242
8. Poli A Tremoli E Colombo A Sirtori M Pignoli P Paoletti R Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects Atherosclerosis 1988, 70(3):253-261. 10.1016/0021-9150(88)90176-1 3284536
9. Pignoli P Tremoli E Poli A Oreste P Paoletti R Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging Circulation 1986, 74(6):1399-1406. 3536154
10. Yamasaki Y Kawamori R Matsushima H Nishizawa H Kodama M Kajimoto Y Morishima T Kamada T Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging Diabetes 1994, 43(5):634-639. 10.2337/diabetes.43.5.634 8168638
11. Handa N Matsumoto M Maeda H Hougaku H Ogawa S Fukunaga R Yoneda S Kimura K Kamada T Ultrasonic evaluation of early carotid atherosclerosis Stroke 1990, 21(11):1567-1572. 2237950
12. Bradley C Diabetes treatment satisfaction questionnaire Handbook of psychology and diabetes Chur: Harwood Academic Publishers Bradley C; 1994.
13. Monnier L Lapinski H Colette C Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA(1c) Diabetes Care 2003, 26(3):881-885. 10.2337/diacare.26.3.881 12610053
14. Woerle HJ Neumann C Zschau S Tenner S Irsigler A Schirra J Gerich JE Goke B Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels Diabetes Res Clin Pract 2007, 77(2):280-285. 10.1016/j.diabres.2006.11.011 17240473
15. Temelkova-Kurktschiev TS Koehler C Henkel E Leonhardt W Fuecker K Hanefeld M Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level Diabetes Care 2000, 23(12):1830-1834. 10.2337/diacare.23.12.1830 11128361
16. Beks PH Mackaay AJ de Vries H de Neeling JN Bouter LM Heine RJ Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population: The Hoorn Study Diabetologia 1997, 40(3):290-298. 10.1007/s001250050676 9084966
17. Bonora E Kiechl S Oberhollenzer F Egger G Bonadonna RC Muggeo M Willeit J Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: Prospective results from the Bruneck Study Diabetologia 2000, 43(2):156-164. 10.1007/s001250050024 10753036
18. Dullaart RP de Vries R van Tol A Sluiter WJ Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender Eur J Endocrinol 2007, 156(3):387-394. 10.1530/EJE-06-0681 17322499
19. Martos-Moreno GA Barrios V Soriano-Guillen L Argente J Relationship between adiponectin levels, acylated ghrelin levels, and short-term body mass index changes in children with diabetes mellitus type 1 at diagnosis and after insulin therapy Eur J Endocrinol 2006, 155(5):757-761. 10.1530/eje.1.02273 17062893
20. Ouchi N Kihara S Arita Y Maeda K Kuriyama H Okamoto Y Hotta K Nishida M Takahashi M Nakamura T et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin Circulation 1999, 100(25):2473-2476. 10604883
21. Fasshauer M Kralisch S Klier M Lossner U Bluher M Klein J Paschke R Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes Biochem Biophys Res Commun 2003, 301(4):1045-1050. 10.1016/S0006-291X(03)00090-1 12589818
22. Ouchi N Kihara S Funahashi T Nakamura T Nishida M Kumada M Okamoto Y Ohashi K et al. Nagaretani H Kishida K Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 2003, 107(5):671-674. 10.1161/01.CIR.0000055188.83694.B3 12578865
23. Gottsater A Szelag B Kangro M Wroblewski M Sundkvist G Plasma adiponectin and serum advanced glycated end-products increase and plasma lipid concentrations decrease with increasing duration of type 2 diabetes Eur J Endocrinol 2004, 151(3):361-366. 10.1530/eje.0.1510361 15362966
24. Monzillo LU Hamdy O Horton ES Ledbury S Mullooly C Jarema C Porter S Ovalle K Moussa A Mantzoros CS Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance Obes Res 2003, 11(9):1048-1054. 10.1038/oby.2003.144 12972674
25. Esposito K Pontillo A Di Palo C Giugliano G Masella M Marfella R Giugliano D Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial Jama 2003, 289(14):1799-1804. 10.1001/jama.289.14.1799 12684358
26. Joshi SR Kalra S Badgandi M Rao YS Chawla M Designer insulins regimens in clinical practice-pilot multicenter Indian study J Assoc Physicians India 2005, 53:775-779. 16334621
27. Holman RR Thorne KI Farmer AJ Davies MJ Keenan JF Paul S Levy JC Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes N Engl J Med 2007, 357(17):1716-1730. 10.1056/NEJMoa075392 17890232